Provided by Tiger Fintech (Singapore) Pte. Ltd.

OptimizeRx Corporation

8.74
+0.08000.92%
Volume:136.12K
Turnover:1.19M
Market Cap:161.61M
PE:-7.95
High:8.97
Open:8.65
Low:8.59
Close:8.66
Loading ...

OptimizeRx initiated with an Equal Weight at Stephens

TIPRANKS
·
20 Dec 2024

Analysts Conflicted on These Healthcare Names: OptimizeRx (OPRX) and Universal Health (UHS)

TIPRANKS
·
17 Dec 2024

OptimizeRx to Participate in Upcoming Investor Conferences

GlobeNewswire
·
18 Nov 2024

OptimizeRx Price Target Cut to $16.00/Share From $20.00 by Roth MKM

Dow Jones
·
15 Nov 2024

OptimizeRx Is Maintained at Buy by Stifel

Dow Jones
·
14 Nov 2024

RBC Cuts Price Target on OptimizeRx to $7 From $14, Keeps Outperform Rating

MT Newswires Live
·
14 Nov 2024

OptimizeRx price target lowered to $5 from $11 at Barclays

TIPRANKS
·
14 Nov 2024

Barclays Sticks to Their Hold Rating for OptimizeRx (OPRX)

TIPRANKS
·
14 Nov 2024

Analysts Have Conflicting Sentiments on These Healthcare Companies: PTC Therapeutics (PTCT), Medtronic (MDT) and OptimizeRx (OPRX)

TIPRANKS
·
14 Nov 2024

OptimizeRx Corp (OPRX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Shifts ...

GuruFocus.com
·
14 Nov 2024

OptimizeRx Corp reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates

Zacks
·
14 Nov 2024

OptimizeRx Q3 2024 Adj. EPS $0.12 Beats $0.06 Estimate, Sales $21.309M Miss $24.997M Estimate

Benzinga
·
14 Nov 2024

OptimizeRx Outlook FY24 Revenue to Be Between $88 Mln and $92 Mln

THOMSON REUTERS
·
14 Nov 2024

OptimizeRx Corp FY2024 REV View $100.7 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
14 Nov 2024

OptimizeRx Q3 Gross Profit USD 13.4 Million

THOMSON REUTERS
·
14 Nov 2024

OptimizeRx Q3 Cash & Investments USD 16.1 Million

THOMSON REUTERS
·
14 Nov 2024

OptimizeRx Q3 Adjusted Ebitda USD 2.7 Million

THOMSON REUTERS
·
14 Nov 2024

OptimizeRx Q3 Adjusted Net Income USD 2.3 Million VS. Ibes Estimate USD 970 Thousand

THOMSON REUTERS
·
14 Nov 2024

OptimizeRx Q3 Gross Margin 63%

THOMSON REUTERS
·
14 Nov 2024